Target Name: MIR4472-1
NCBI ID: G100616268
Review Report on MIR4472-1 Target / Biomarker Content of Review Report on MIR4472-1 Target / Biomarker
MIR4472-1
Other Name(s): hsa-miR-4472 | MicroRNA 4472-1 | hsa-mir-4472-1 | microRNA 4472-1

MIR4472-1: A Drug Target / Disease Biomarker

MIR4472-1 is a protein that is expressed in various tissues of the body, including the brain, heart, and lungs. It is a member of the Mir gene family, which encodes a family of transmembrane proteins that are involved in various cellular processes. One of the main functions of MIR4472-1 is to regulate the expression of genes in the brain, which is why it is of interest as a potential drug target or biomarker.

The brain is a complex organ that is responsible for controlling all of the body's functions, including movement, speech, and thought. The brain is also home to a large number of genes that are responsible for its development and function. However, these genes can be turned on or off by a variety of factors, including the levels of certain hormones or the presence of certain viruses. MIR4472-1 is involved in regulating the expression of these genes, which is important for the proper functioning of the brain.

One of the ways that MIR4472-1 is involved in brain function is by regulating the activity of a protein called NF-kappa-B. NF-kappa-B is a signaling molecule that is involved in many different processes in the brain, including the regulation of inflammation, stress responses, and neural development. MIR4472-1 has been shown to interact with NF-kappa-B and to regulate its activity. This suggests that MIR4472-1 may be a useful drug target or biomarker for the treatment of conditions that are related to the activity of NF-kappa-B.

Another way that MIR4472-1 is involved in brain function is by regulating the activity of a protein called TGF-β. TGF-β is a signaling molecule that is involved in the regulation of cell growth, differentiation, and inflammation. MIR4472-1 has been shown to interact with TGF-β and to regulate its activity. This suggests that MIR4472-1 may be a useful drug target or biomarker for the treatment of conditions that are related to the activity of TGF-β.

In addition to its role in regulating the activity of NF-kappa-B and TGF-β, MIR4472-1 is also involved in the regulation of the production of other proteins in the brain. This suggests that MIR4472-1 may be a useful drug target or biomarker for the treatment of conditions that are related to the regulation of protein synthesis in the brain.

MIR4472-1 is also of interest as a potential drug target because it is expressed in a variety of tissues and organs, including the brain. This means that it may be possible to target MIR4472-1 using a variety of different techniques, such as small molecules, antibodies, or other therapeutic agents. This may make it easier to develop a treatment for MIR4472-1-related conditions.

In conclusion, MIR4472-1 is a protein that is expressed in various tissues of the body, including the brain. It is involved in regulating the expression of genes in the brain and is thought to be a potential drug target or biomarker for the treatment of conditions related to the activity of NF-kappa-B, TGF-β, and protein synthesis in the brain. Further research is needed to fully understand the role of MIR4472-1 in the regulation of brain function and the potential uses of MIR4472-1 as a drug.

Protein Name: MicroRNA 4472-1

The "MIR4472-1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4472-1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR4472-2 | MIR4474 | MIR4475 | MIR4476 | MIR4478 | MIR4479 | MIR448 | MIR4481 | MIR4482 | MIR4483 | MIR4484 | MIR4485 | MIR4486 | MIR4487 | MIR4488 | MIR4489 | MIR4491 | MIR4492 | MIR4493 | MIR4496 | MIR4497 | MIR4498 | MIR4499 | MIR449A | MIR449B | MIR449C | MIR4500 | MIR4500HG | MIR4501 | MIR4504 | MIR4505 | MIR4506 | MIR4507 | MIR4508 | MIR4509-1 | MIR4509-2 | MIR4509-3 | MIR450A1 | MIR450A2 | MIR450B | MIR4510 | MIR4511 | MIR4512 | MIR4513 | MIR4514 | MIR4516 | MIR4519 | MIR451A | MIR451B | MIR452 | MIR4520-1 | MIR4520-2 | MIR4521 | MIR4524A | MIR4524B | MIR4525 | MIR4526 | MIR4527 | MIR4527HG | MIR4529 | MIR4530 | MIR4531 | MIR4533 | MIR4534 | MIR4535 | MIR4536-1 | MIR4536-2 | MIR4537 | MIR4538 | MIR4539 | MIR454 | MIR4540 | MIR455 | MIR4632 | MIR4633 | MIR4634 | MIR4635 | MIR4638 | MIR4639 | MIR4640 | MIR4641 | MIR4642 | MIR4644 | MIR4645 | MIR4646 | MIR4647 | MIR4648 | MIR4649 | MIR4650-1 | MIR4650-2 | MIR4651 | MIR4652 | MIR4653 | MIR4655 | MIR4656 | MIR4657 | MIR4658 | MIR4659A | MIR4659B | MIR466